Healthcare -
Biotechnology - NASDAQ - US
$ 7.87
6.21 %
$ 666 M
Market Cap
-3.2
P/E
VERV - SHORT-TERM DEBT
Short-term Debt VERV - Verve Therapeutics, Inc.
10.2 M
LAST VALUE
61.45%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR